SOW
AMRX icon

State of Wyoming’s Amneal Pharmaceuticals AMRX Stock Holding History

State of Wyoming’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$501K Sell
28,930
-27,548
-49% -$377K 0.05% 404
2026
Q1 		$702K Buy
56,478
+12,888
+30% +$173K 0.08% 172
2025
Q4 		$549K Sell
43,590
-13,094
-23% -$150K 0.06% 317
2025
Q3 		$567K Buy
56,684
+5,225
+10% +$46.9K 0.06% 252
2025
Q2 		$416K Sell
51,459
-30,313
-37% -$229K 0.05% 398
2025
Q1 		$685K Buy
81,772
+43,320
+113% +$362K 0.09% 126
2024
Q4 		$305K Sell
38,452
-4,184
-10% -$35.1K 0.04% 545
2024
Q3 		$355K Sell
42,636
-10,116
-19% -$79.1K 0.05% 339
2024
Q2 		$335K Sell
52,752
-5,374
-9% -$34.1K 0.06% 262
2024
Q1 		$352K Sell
58,126
-22,611
-28% -$128K 0.06% 268
2023
Q4 		$490K Buy
80,737
+8,060
+11% +$35.9K 0.09% 120
2023
Q3 		$307K Sell
72,677
-20,093
-22% -$74.9K 0.07% 216
2023
Q2 		$288K Buy
92,770
+7,143
+8% +$15.2K 0.08% 204
2023
Q1 		$119K Buy
85,627
+9,369
+12% +$18.7K 0.04% 662
2022
Q4 		$152K Buy
76,258
+24,333
+47% +$54.5K 0.05% 519
2022
Q3 		$105K Buy
51,925
+23,807
+85% +$66.7K 0.05% 570
2022
Q2 		$89K Buy
28,118
+7,020
+33% +$25.4K 0.06% 567
2022
Q1 		$88K Buy
21,098
+1,142
+6% +$5.06K 0.04% 691
2021
Q4 		$96K Buy
+19,956
New +$99.5K 0.04% 657

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State of Wyoming's AMRX Position: Q2 2026 in Review

State of Wyoming reduced its Amneal Pharmaceuticals (AMRX) stake by 49% in Q2 2026, selling an estimated $377K and leaving 28,930 shares worth $501K. The position accounts for 0.05% of the portfolio, ranked #404.

State of Wyoming first reported a position in AMRX in Q4 2021 and has held it in 19 quarters since. The position peaked at $702K in Q1 2026. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • State of Wyoming held 28,930 shares of Amneal Pharmaceuticals worth $501K as of Q2 2026.
  • State of Wyoming sold 27,548 Amneal Pharmaceuticals shares in Q2 2026, an estimated $377K.
  • Amneal Pharmaceuticals made up 0.05% of State of Wyoming's portfolio in Q2 2026, its #404 holding.
  • State of Wyoming first reported a position in Amneal Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • State of Wyoming's Amneal Pharmaceuticals position peaked at $702K in Q1 2026.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.